Vistagen adds Douglas J. Williamson to board of directors
The neuroscience drug development veteran joins as Vistagen advances its pherine pipeline, including Phase 3 fasedienol for social anxiety disorder.
SEC filing
Latest
2 stories
Sign inSign in2 stories
The neuroscience drug development veteran joins as Vistagen advances its pherine pipeline, including Phase 3 fasedienol for social anxiety disorder.
SEC filing